Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients (Journal article)

Georgiadis, A. N./ Voulgari, P. V./ Argyropoulou, M. I./ Alamanos, Y./ Elisaf, M. S./ Tselepis, A. D./ Drosos, A. A.

Full metadata record
DC FieldValueLanguage
dc.contributor.authorGeorgiadis, A. N.en
dc.contributor.authorVoulgari, P. V.en
dc.contributor.authorArgyropoulou, M. I.en
dc.contributor.authorAlamanos, Y.en
dc.contributor.authorElisaf, M. S.en
dc.contributor.authorTselepis, A. D.en
dc.contributor.authorDrosos, A. A.en
dc.rightsDefault Licence-
dc.subjectArthritis, Rheumatoid/complications/*drug therapyen
dc.subjectCardiovascular Diseases/*complicationsen
dc.subjectImmunosuppressive Agents/*therapeutic useen
dc.subjectMethotrexate/therapeutic useen
dc.subjectMiddle Ageden
dc.subjectPrednisone/therapeutic useen
dc.subjectRisk Factorsen
dc.titleEarly treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patientsen
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.abstractOBJECTIVE: To investigate subclinical atherosclerosis and the effect of treatment in patients with early rheumatoid arthritis (RA). PATIENTS AND METHODS: Forty patients with early RA who met the revised American College of Rheumatology (ACR) criteria and disease duration of <1 year were included in the study. Smokers and patients with classical risk factors for atherosclerosis were excluded. The serum levels of total cholesterol (TC), triglycerides, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol were determined in all patients before and after 1 year of therapy. Carotid artery intima-media thickness (IMT) and carotid plaque were measured before and after treatment. RA disease activity was measured using the 28 joint indices score (DAS-28) and clinical improvement was determined by the ACR response criteria. Forty-five age- and sex-matched nonsmoking volunteers were used as controls. All patients were treated with methotrexate and prednisone. RESULTS: RA patients had a baseline mild dyslipidemia characterized by a decrease in serum HDL-C levels and a high TC/HDL-C atherogenic ratio compared with controls. Both lipid parameters were significantly improved after treatment (P<0.01). Common carotid artery IMTs at baseline were higher in RA patients compared with controls (P<0.05). After 1 year of therapy there was a significant decrease in the IMTs (P<0.001). Thirty-five patients (88%) achieved the ACR 20%, while 30 (75%) reached the ACR 50% response criteria. A significant decrease of DAS-28 was observed after treatment (P<0.03). CONCLUSIONS: The atherogenic lipid profile and subclinical atherosclerosis are features of early RA, which improved after therapy. Early intervention and control of the disease activity may reduce the risk of atherosclerosis and cardiovascular events in patients with RA.en
heal.journalNameSemin Arthritis Rheumen
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Georgiadis-2008-Early treatment redu.pdf260.23 kBAdobe PDFView/Open    Request a copy

 Please use this identifier to cite or link to this item:
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.